Brief: Chiome Bioscience says patent for humanized TROP-2 antibody granted in Japan
Nov 2 (Reuters) - Chiome Bioscience Inc 4583.T :
* Says it received a notice of allowance on Nov. 1 that a
patent application has been granted by Japan Patent Office
regarding the anti-human TROP-2 antibody having an anti-tumor
activity in vivo
Source text in Japanese: https://goo.gl/pf2wxB
Further company Coverage: 4583.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))